Asensus Surgical Announces First Towakai Hospital in Japan to Initiate Senhance Surgery Program
23 Août 2023 - 12:55PM
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient to pioneer a new era of Performance-Guided Surgery™,
today announced that First Towakai Hospital has entered into an
agreement to lease and utilize a Senhance® Surgical System in their
urology and gynecology centers (Urogynecology center) and
gastroenterology department.
“We’re thrilled about our collaboration with First Towakai
Hospital in Japan, especially in the Urogynecology department,”
said Anthony Fernando, Asensus Surgical President, and CEO. “Their
commitment to cutting-edge care aligns with our vision for growth
in this crucial region. Dr. Masami Takeyama, head of the
Urogynecology center, is a respected figure, and his pioneering
efforts have contributed significantly to the growth of innovative
surgical techniques in the region. As we expand our presence not
only in Japan but also in other key regions worldwide, we are
driven by the commitment to provide high-quality care for
patients.”
“Our primary focus is on delivering the best possible care to
our patients, and the Senhance System will play a significant role
in strengthening our robotic surgery department and improving
patient outcomes,” said Dr. Kyouko Onishi, Owner and Chairman of
Board of First Towakai Hospital. Dr. Masami Takeyama, head of the
Urogynecology center further commented, “We are also excited about
Asensus Surgical’s dedication to innovation. We look forward to
exploring new possibilities together and continuously enhancing our
surgical capabilities to provide even better care for our
patients.”
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/4b908d17-0606-41ba-a6cd-d99ec3f5e3ff
The Senhance Surgical System is designed to increase surgeon
control through the addition of machine vision, Augmented
Intelligence, and deep learning capabilities.
About First Towakai Hospital
First Towakai Hospital is a prominent community-based medical
institution situated in Takatsuki City, Osaka Prefecture. Known for
its unwavering commitment to excellence in healthcare, the hospital
continually integrates cutting-edge medical technology to ensure
precise diagnoses and enhanced medical support. Dedicated to
serving the community, First Towakai Hospital strives to empower
the well-being of its patients through a combination of
state-of-the-art medical advancements and personalized care.
Established in June 1982, the hospital boasts 243 acute beds and
excels in performing approximately 1,000 endoscopic surgeries
annually. Among these, it specializes in 150 Laparoscopic
sacrocolpopexy (LSC) cases each year.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. Based
upon the foundations of Digital Laparoscopy and the Senhance
Surgical System, the Company is developing the LUNA™ Surgical
System, a next generation robotic and instrument system as a
foundation of its Digital Surgery solution. These systems will be
powered by the Intelligent Surgical Unit™ to increase surgeon
control and reduce surgical variability. With the addition of
machine vision, Augmented Intelligence, and deep learning
capabilities throughout the surgical experience, we intend to
holistically address the current clinical, cognitive and economic
shortcomings that drive surgical outcomes and value-based
healthcare. The Senhance Surgical System is now available for sale
in the US, EU, Japan, Russia, and select other countries. For a
complete list of indications for use, visit:
www.senhance.com/indications. To learn more about
Performance-Guided Surgery, and digital laparoscopy with the
Senhance Surgical System visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/@AsensusSurgical
Vimeo: https://vimeo.com/asxc
TikTok: https://www.tiktok.com/@asensus_surgical
Forward-Looking Statements
This press release includes statements relating to the Senhance
Surgical System and First Towakai Hospital in Osaka, Japan
initiating a program with the Senhance System. These statements and
other statements regarding our future plans and goals constitute
“forward looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, and are intended to qualify for the safe
harbor from liability established by the Private Securities
Litigation Reform Act of 1995. Such statements are subject to risks
and uncertainties that are often difficult to predict, are beyond
our control and which may cause results to differ materially from
expectations and include whether First Towakai Hospital’s
commitment to cutting-edge care aligns with Asensus Surgical’s
vision for growth in the region and whether the Senhance Surgical
System will play a significant role in strengthening First Towakai
Hospital’s robotic surgery department and improving patient
outcomes. For a discussion of the risks and uncertainties
associated with the Company’s business, please review our filings
with the Securities and Exchange Commission (SEC), including our
Annual Report on Form 10-K for the year ended December 31, 2022,
filed with the SEC on March 2, 2023 and our other filings we make
with the SEC. You are cautioned not to place undue reliance on
these forward looking statements, which are based on our
expectations as of the date of this press release and speak only as
of the origination date of this press release. We undertake no
obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com
MEDIA CONTACT:
Dan Ventresca
Matter Communications
AsensusPR@matternow.com
617-874-5488
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024